Article
Alexion Gets CHMP Nod for New Ultomiris Formulation
Rating:
0.0
Views:
72
Likes:
1
Library:
1
The Committee for Medicinal Products for Human Use (CHMP) recommendation for ravulizumab (Ultomiris) is for a dosage that involves a less rigorous schedule for administration.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value